Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Innovation Council · Finished

BIC ONE Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation

Coordinator
Cortec GmbH, Germany
Runs
1 November 2022 to 31 October 2024
Status
Finished
EU funding
€2.5m
Total cost
€3.7m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190118958

What the project is doing

In the project's own words, from its summary on CORDIS.

Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders. Most of the devices for this novel approach are based on the old pacemaker technology. Companies are unwilling to take device development risks & rely on established tech, limiting new therapy developments. Many neurological diseases are still treated with pharmaceuticals only, which has limited effectiveness and causes severe side effects.

Neuromodulation—electrical stimulation research has increased in recent decades. Additional recording capabilities & closed loop therapy expand therapeutic options. CorTec aims to provide novel implantable tech to overcome the current limitations: it enables researchers, medical institutions & industry to develop new therapies & devices. We plan to finalise the development of our tech for stroke rehabilitation, conduct clinical trials & get market approval in 2029, generating €250M in sales in 2030.

Topics

Who is involved

OrganisationCityCountryRole
Cortec GmbHFreiburg Im BreisgauGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI